Teva Hit With Class-action Suit by Shareholders in NY Court

Lawsuit claims firm's stock price was inflated because executives failed to disclose conflicts between management and the board.

comments Print
A class-action lawsuit has been filed against Teva Pharmaceutical Industries in New York federal court on behalf of shareholders who claim that company executives misrepresented Teva’s financial state.